NexImmune Inc. announced the appointment of Leena Gandhi, M.D., Ph.D., Director for the Center of Therapeutic Innovation at Dana-Farber Cancer Institute, to its Board of Directors as a Non-Executive Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +1.91% | +2.89% | +44.14% |
20/05 | NexImmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+44.14% | 4.31M | |
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |
- Stock Market
- Equities
- NEXI Stock
- News NexImmune, Inc.
- NexImmune Inc. Appoints Leena Gandhi to Board of Directors as a Non-Executive Director